Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis

Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome

NCT05444946 ·Status: RECRUITING ·Phase: NA

A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients

NCT06099236 ·Status: ACTIVE_NOT_RECRUITING

Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.

NCT04157348 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Local Spraying of GM-CSF Via Bronchoscopy in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis

NCT06989333 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Safety Study of Abatacept to Treat Refractory Sarcoidosis

NCT00739960 ·Status: TERMINATED ·Phase: PHASE2

Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

NCT00315380 ·Status: RECRUITING

This Study Aim is to Compare the Effect of Oral Methyl Prednisolone on Different Radiological Patterns of Hypersensitivity Pneumonitis as it Was Found That Not All Patients Get Satisfying Therapeutic Effect After Taking Corticosteroids.

NCT04402177 ·Status: UNKNOWN ·Phase: PHASE4

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

NCT07444567 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA

NCT07343661 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4

Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)

NCT02243228 ·Status: UNKNOWN ·Phase: PHASE2

Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung Disease

NCT03770663 ·Status: UNKNOWN ·Phase: PHASE3

Deflazacort Vs. Prednisolone in Acute-stage ABPA

NCT04227483 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

A Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in Brazil

NCT04228588 ·Status: UNKNOWN ·Phase: PHASE4

Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis

NCT00001541 ·Status: COMPLETED

Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis

NCT03316651 ·Status: UNKNOWN ·Phase: PHASE2

Rituximab in the First Episode of Paediatric Nephrotic Syndrome

NCT05850546 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.

NCT02160132 ·Status: UNKNOWN ·Phase: PHASE2

Multi-model Image of Immunosuppressive Agents in TAO

NCT05110040 ·Status: RECRUITING ·Phase: NA

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

NCT06868290 ·Status: RECRUITING ·Phase: PHASE2

Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis

NCT02888080 ·Status: COMPLETED ·Phase: PHASE2

Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome

NCT05845723 ·Status: RECRUITING ·Phase: PHASE2

Somatostatin Receptor Imaging in Cardiac Sarcoidosis

NCT02812849 ·Status: WITHDRAWN

The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children

NCT02532790 ·Status: UNKNOWN ·Phase: PHASE2

Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis

NCT02126098 ·Status: UNKNOWN

Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides

NCT00001473 ·Status: COMPLETED